A New Prognostic Score Supporting Treatment Allocation for Multimodality Therapy for Malignant Pleural Mesothelioma: A Review of 12 Years’ Experience
暂无分享,去创建一个
B. Seifert | R. Stahel | T. Frauenfelder | W. Klepetko | M. A. Hoda | W. Weder | T. Nguyen-Kim | D. Schneiter | P. Kestenholz | I. Opitz | M. Friess | M. Hoda
[1] P. Pairolero,et al. Malignant pleural mesothelioma: surgical management in 285 patients. , 2008, The Annals of thoracic surgery.
[2] Cristián Zegers Ariztía,et al. Manual , 2002 .
[3] E. Ruffini,et al. The management of malignant pleural mesothelioma. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[4] R. Govindan,et al. Biostatistics primer: what a clinician ought to know--prognostic and predictive factors. , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[5] C. Obasaju,et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[7] V. Rusch,et al. The importance of surgical staging in the treatment of malignant pleural mesothelioma. , 1996, The Journal of thoracic and cardiovascular surgery.
[8] G. Giaccone,et al. Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] P. Bannon,et al. Summary of Prognostic Factors and Patient Selection for Extrapleural Pneumonectomy in the Treatment of Malignant Pleural Mesothelioma , 2011, Annals of Surgical Oncology.
[10] V. Rusch,et al. Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[11] J. Shamash,et al. Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] R. Stahel,et al. Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] M. Byrne,et al. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] R. Stupp,et al. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] Jean-François Dartigues,et al. Review and comparison of ROC curve estimators for a time-dependent outcome with marker-dependent censoring. , 2013, Biometrical journal. Biometrische Zeitschrift.
[16] G. Reid,et al. Circulating microRNAs: Association with disease and potential use as biomarkers. , 2011, Critical reviews in oncology/hematology.
[17] A. Jilaihawi,et al. The management of malignant pleural mesothelioma; single centre experience in 10 years. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[18] S J Mentzer,et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. , 1996, Annals of surgery.
[19] B. Ghanim,et al. Pretreatment Serum C-Reactive Protein Levels Predict Benefit From Multimodality Treatment Including Radical Surgery in Malignant Pleural Mesothelioma: A Retrospective Multicenter Analysis , 2012, Annals of surgery.
[20] B. Seifert,et al. Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma? , 2011, European Respiratory Journal.
[21] B. McCaughan,et al. A Systematic Review of Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[22] V. Mehta,et al. Trimodality therapy for malignant pleural mesothelioma. , 2009, The Annals of thoracic surgery.
[23] G. Reid,et al. MiR‐Score: A novel 6‐microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma , 2015, Molecular oncology.
[24] Junxing Huang,et al. Elevated pre-treatment levels of high sensitivity C-reactive protein as a potential prognosticator in patients with colorectal cancer , 2013, Experimental and therapeutic medicine.
[25] S. Steinberg,et al. Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma. , 1998, The Journal of thoracic and cardiovascular surgery.
[26] Han-Soo Kim,et al. Elevated Preoperative Systemic Inflammatory Markers Predict Poor Outcome in Localized Soft Tissue Sarcoma , 2014, Annals of Surgical Oncology.
[27] A. Bezjak,et al. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Shin Matsuoka,et al. Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume. , 2012, AJR. American journal of roentgenology.